Citius Pharma (CTXR). Reports Fiscal First Quarter 2023 Financial Results and Provides Business Update
$36.9 million in cash and cash equivalents as of December 31, 2022 ; runway through February 2024
Uptick in patient recruitment for Mino-Lok® Phase 3 trial
Halo-Lido Phase 2b trial nearing completion
CRANFORD,...
Ohio State University Completes Study on Pressure Bioscience (PBIO) and Protein Drinks.
Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market.
Recent Study Published by The Ohio...
Interview: Ric Schumacher CEO, Pressure Bioscience (PBIO)
Our favorite interview to date, and there have been dozens. Filmed November of 2021, and the story has gotten to much better since.
https://vimeo.com/652106617
$PBIO,...
Latest article
GeoVax (GOVX) Monkeypox (MPOX) PowerPoint.
In a recent press release, GeoVax shared progress on their MPOX Vaccine.
The planned Phase 3 immuno-bridging arm of the clinical trial is expected to...
Rick Rule Symposium – Conference Cheat Sheet
Natural Resource Investing Symposium - Presenter Guide
We've attended hundreds and hundreds of Investment Conferences (Barclay, JP Morgan, LD Micro, Piper Sandler, Roth, VRIC) since...
GeoVax (GOVX) Surges 256%, With 207 Million Shares Trading!
What an Entertaining Week!
..and it's only Thursday.
LIVE QUOTE
(MAY 18TH)
(MAY 21ST)
So Where Does That Leave us Today?
Yes, it was a pleasant surprise to see GeoVax...
